Person:
Raskin, Kevin

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Raskin

First Name

Kevin

Name

Raskin, Kevin

Filters

2010 - 20163

Settings

Author's Publications: search.filters.isAuthorOfPublication.e20cb55c-8b9a-433f-91d0-d27854edaee7

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    Publication
    The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases
    (Hindawi Publishing Corporation, 2016) Janssen, Stein J.; van Rein, Eva A. J.; Paulino Pereira, Nuno Rui; Raskin, Kevin; Ferrone, Marco; Hornicek, Francis; Lozano-Calderon, Santiago A.; Schwab, Joseph
    Background:. The Musculoskeletal Tumor Society (MSTS) scoring system measures function and is commonly used but criticized because it was developed to be completed by the clinician and not by the patient. We therefore evaluated if there is a difference between patient and clinician reported function using the MSTS score. Methods. 128 patients with bone metastasis of the lower (n = 100) and upper (n = 28) extremity completed the MSTS score. The MSTS score consists of six domains, scored on a 0 to 5 scale and transformed into an overall score ranging from 0 to 100% with a higher score indicating better function. The MSTS score was also derived from clinicians' reports in the medical record. Results. The median age was 63 years (interquartile range [IQR]: 55–71) and the study included 74 (58%) women. We found that the clinicians' MSTS score (median: 65, IQR: 49–83) overestimated the function as compared to the patient perceived score (median: 57, IQR: 40–70) by 8 points (p < 0.001). Conclusion. Clinician reports overestimate function as compared to the patient perceived score. This is important for acknowledging when informing patients about the expected outcome of treatment and for understanding patients' perceptions.
  • Thumbnail Image
    Publication
    Osteoblastoma-like Osteosarcoma of the Cuboid: A Case Report
    (BioMed Central, 2010) Kumar, Navin; Rosenberg, Andrew Eric; Raskin, Kevin
    Osteosarcoma most commonly arises in the long bones of the skeleton, and rarely develops in the bones of the foot. We describe a patient who presented with left foot pain, whose radiographic evaluation revealed a lytic destructive mass in the cuboid bone. A biopsy showed an osteoblastoma-like variant of osteosarcoma and the patient was treated with preoperative chemotherapy and amputation. Osteosarcoma of the foot is uncommon and the literature reveals that it is often associated with a delay in diagnosis.
  • Thumbnail Image
    Publication
    Intraosseous Synovial Sarcoma of the Proximal Tibia
    (Hindawi Publishing Corporation, 2011) Beck, Sarah E.; Nielsen, Gunnlaugur; Raskin, Kevin; Schwab, Joseph
    Synovial Sarcoma is a malignant mesenchymal tumor that comprises 5–10% of all soft tissue sarcomas. The mean age of onset is thirty years old. Intraosseous presentation is very rare and has only been documented a few times. We report herein a case of a 53-year-old man with synovial sarcoma arising in the left proximal tibia. The patient underwent a wide surgical resection and reconstruction, followed by adjuvant chemotherapy. Three years later, the patient developed a local recurrence that resulted in an above-the-knee amputation. Eight months later, the patient has completed chemotherapy and is without signs of recurrence. The current recommended treatment for synovial sarcoma is wide surgical resection followed by chemotherapy as well as long-term followup. Despite improved surgical techniques, long-term survival rates remain low.